DB18485InvestigationalProtein Based Therapies
ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.
- Code names
- CJ-40002
What you can answer from here — as of September 28, 2023
Which companies are running trials of ALT-P1, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account